Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Editorial] Neuraminidase inhibitors for influenza: a call for better research

On Oct 8, the Academy of Medical Sciences and the Wellcome Trust (AMS/WT) published a timely report on the use of neuraminidase inhibitor (NAI) antiviral drugs in seasonal and pandemic influenza treatment and prophylaxis. As winter approaches in the UK, the debate about whether the benefit of routine use of NAIs outweighs the risks of side-effects, such as nausea and vomiting continues; a meta-analysis published in The Lancet in January explored this issue in oseltamivir use for seasonal influenza.